Obsessive-compulsive symptoms treatment in schizophrenia;Le traitement des symptômes obsessionnels-compulsifs dans la schizophrénie

Canadian Journal of Psychiatry

Volumn 50, Issue 7, 2005, Pages 423-428

  Faucher, Sophie ^a   Dardennes, Roland ^b,c   Ghaëm, Olivier ^b   Guelfi, Julien Daniel ^b  

^a Policlinique Wurtz   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Service du Professeur J D Guelfi   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; CLOZAPINE; FLUVOXAMINE; OLANZAPINE; RISPERIDONE;

ANAMNESIS; ARTICLE; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG EFFICACY; FAMILY HISTORY; HUMAN; OBSESSIVE COMPULSIVE DISORDER; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 31544452269     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370505000706     Document Type: Article

References (59)

1. Tibbo P, Warneke L. Obsessive-compulsive disorder in schizophrenia: epidemiologic and biologic overlap. J Psychiatry Neurosci 1992;24:15-24.
2. Dowling FG, Pato MT, Pato CN. Comorbidity of obsessive and compulsive symptoms and psychotic symptoms: a review. Harv Rev Psychiatry 1995;3:75- 83.
3. Berman I, Merson A, Viegner B, Losonczy MF, Pappas D, Green AI. Obsessions and compulsions as a distinct cluster of schizophrenia: a neuropsychopharmacological study. J Nerv Ment Dis 1998;156:150 -6.
4. Cassady SL, Thaker GK. Addition of fluoxetine to clozapine. Am J Psychiatry 1992;149:274.
5. Patil VJ. Development of transient obsessive-compulsive symptoms during treatment with clozapine. Am J Psychiatry 1992;149:272.
6. Patel B, Tandon R. Development of obsessive-compulsive disorder symptoms during clozapine treatment. Am J Psychiatry 1993;150:386.
7. Allen L, Tejera C. Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline. Am J Psychiatry 1994;151:1096-7.
8. Eales MJ, Layeni AO. Exacerbation of obsessive-compulsive symptoms associated with clozapine. Br J Psychiatry 1994;164:687- 8.
9. Mozes P, Toren P, Chernauzan N, Mester R, Yoran-Hegesh R, Blumensohn R et coll. Clozapine treatment in very early onset schizophrenia. J Am Acad Child Adolesc Psychiatry 1994;33:65-70.
10. Buckley PF, Sajatovic M, Meltzer HY. Treatment of delusional disorders with clozapine. Am J Psychiatry 1994;15:1394-5.
11. Levkovitch Y, Kronnenberg Y, Gaoni B.Can clozapine trigger OCD ? J Am Acad Child Adolesc Psychiatry 1995;34:263.
12. Markowitz JS, Gill HS, Lavia M, Brewerton TD, De Vane CL. Fluvoxamine-clozapine dose-dependant interaction. Can J Psychiatry 1996 41:670-1.
13. Poyurovsky M, Hermesh H, Weizman A. Fluvoxamine treatment clozapine induced obsessive-compulsive symptoms in schizophrenic patients. Clin Neuropharmacol 1996;19:305-13.
14. Rahman MS, Grace JJ, Pato MT, Priest B. Sertraline in the treatment of clozapine induced obsessive-compulsive behavior. Am J Psychiatry 1998;155:1629-30.
15. Strous RD, Patel JK, Zimmet S, Green AI. Clozapine and paroxetine in the treatment of schizophrenia with obsessive-compulsive disorder. Am J Psychiatry 1999;156:973-4.
16. MacCabe JH, Marks IM, Murray RM. Behavior therapy attenuates clozapine-induced obsessions and compulsions. J Clin Psychiatry 2002;63:1179-80.
17. Baker RW, Roy Chengappa KN, Baird JW, Steingard S, Christ MA, Schooler NR. Emergence of obsessive-compulsive symptoms during treatment with clozapine. J Clin Psychiatry 1992;53:439-42.
18. Ghaemi SN, Zarate CA, Popli AP, Pillay SS, Cole JO.Is there a relationship between clozapine and obsessive-compulsive disorder? A retrospective chart review. Compr Psychiatry 1995;36:267-70.
19. De Haan L, Linszen DH, Gorsira R. Clozapine and obsessions in patients with recent onset schizophrenia and others psychotic disorders. J Clin Psychiatry 1999;60:364-6.
20. Kopala L, Honer WG. Risperidone, serotoninergic mechanisms, and obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry 1994;151:1714-5.
21. Remington G, Adams M. Risperidone and obsessive compulsive symptoms. J Clin Psychopharmacol 1994;14:358-9.
22. Dryden-Edwards RC, Reiss AL. Differential response of psychotic and obsessive symptoms to risperidone in an adolescent. J Child Adolesc Psychopharmacol 1996;6:139-45.
23. Alzaid K, Jones BD. A case report of risperidone induced obsessive-compulsive symptoms. J Clin Psychopharmacol 1997;17:58-9.
24. Dodt JE, Bierly MJ, Cuadros C, Christensen RC. Treatment of risperidone-induced obsessive-compulsive symptoms with sertraline. Am J Psychiatry 1997;154:582.
25. Mahendran R. Obsessional symptoms associated with risperidone treatment. Aust N Z J Psychiatry 1998;32:299-301.
26. Lykouras L, Zervas IM, Gournellis R, Malliori M, Rabavilas A. Olanzapine and obsessive-compulsive symptoms. Eur Neuropsychopharmacol 2000;10:385-7.
27. Morrison D, Clark D, Golfarb E, McCoy L. Worsening obsessive-compulsive symptoms following treatment with olanzapine. Am J Psychiatry 1998;155:855.
28. Mottard JP, De la Sablonnière JF. Olanzapine-induced obsessive-compulsive symptoms. Am J Psychiatry 1999;156:799-800.
29. Baker RW, Ames D,Umbricht DSG, Roy Chemgappa KN, Schooler NR. Obsessive and compulsive symptoms in schizophrenia: a comparison of olanzapine and placebo. Psychopharmacol Bull 1996;32:89-93.
30. Toren P, Samuel E, Weizman R, Golomb A, Eldar S, Laor N. Case study: emergence of transient compulsive symptoms during treatment with clothiapine. J Am Acad Child Adolesc Psychiatry 1995;34:1469-72.
31. Howland RH. Chlorpromazine and obsessive compulsive symptoms. Am J Psychiatry 1996;153:1503.
32. Saxena S, Wang D, Bystritsky A, Baxter LR. Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder. J Clin Psychiatry 1996;57:303-6.
33. Ramasubbu R, Ravindran A, Lapierre Y. Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs. Pharmacopsychiatry 2000;33:236-8.
34. Mahendran R. Obsessive-compulsive symptoms with risperidone [letter with reply: Andrade replies and Saxena replies]. J Clin Psychiatry 1999;60:261-2.
35. Gurevich EV, Joyce JN. Alterations in the cortical serotoninergic systems in schizophrenia: a post-mortem study. Biol Psychiatry 1997;42:529-45.
36. The Expert Consensus Panel for Obsessive-Compulsive Disorder. Treatment of obsessive-compulsive disorder. J Clin Psychiatry 1997;58(Suppl 4):2-72.
37. Bark N, Lindenmayer JP. Ineffectivness of clomipramine for obsessive-compulsive symptoms in a patient with schizophrenia. Am J Psychiatry 1992;149:136-7.
38. Tejera CA, Mayerhoff DI, Ramos-Lorenzi J. Clomipramine for obsessive-compulsive symptoms in schizophrenia. J Clin Psychopharmacol 1993;13:290-1.
39. Kurokawa K, Tanino R. Effectivness of clomipramine for obsessive-compulsive symptoms and chronic pain in two patients with schizophrenia. J Clin Psychopharmacol 1997;17:329-30.
40. Poyurovsky M, Weizman A. Intravenous clomipramine for a schizophrenic patient with obsessive-compulsive symptoms. Am J Psychiatry 1998;155:993.
41. Zohar J, Kaplan Z, Benjamin J. Clomipramine treatment of obsessive-compulsive symptomatology in schizophrenic patients. J Clin Psychiatry 1993;54:385-8.
42. Berman I, Sapers B, Chang H, Losonczy M, Schildler J, Green A. Treatment of obsessive-compulsive symptoms in schizophrenic patients with clomipramine. J Clin Psychopharmacol 1995;15:206-10.
43. The Clomipramine Collaborative Study Group. Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1991;48:754-6.
44. Stroebel C, Szarek B, Glueck B. Use of clomipramine in treatment of obsessive-compulsive symptomatology. J Clin Psychopharmacol 1984;4:98-100.
45. Zohar J, Insel TR. Diagnosis and treatment of obsessive-compulsive disorder. Psychiatr Ann 1988;18:168-71.
46. Zohar J, Foa B, Insel TR. Obsessive-compulsive disorders: behavior therapy and pharmacotherapy. In: American Psychiatric Association Task Force. Treatment of psychiatric disorders. Volume 3. Washington (DC): American Psychiatric Association; 1989. p 2095-105.
47. Siris SG, Morgan V, Fagerstrom R, Rifkin A, Cooper TB. Adjunctive imipramine in the treatment of postpsychotic depression: a controlled trial. Arch Gen Psychiatry 1987;44:533-9.
48. Dufresne RL, Kass DJ, Becker RE. Bupropion and thiothixene versus placebo and thiothixene in the treatment of depression in schizophrenia. Drug Dev Res 1988;12:259-66.
49. Lindenmayer JP, Vakharia M, Kanofsky D. Fluoxetine in chronic schizophrenia. J Clin Psychopharmacol 1990;10:76.
50. Baker RW. Fluoxetine and schizophrenia in a patient with obsessional thinking. J Neuropsychiatry Clin Neurosci 1992;4:232-3.
51. Hwang MY, Martin AM, Lindenmayer JP, Stein D, Hollander E. Treatment of schizophrenia with obsessive-compulsive features with serotonin reuptake inhibitors. Am J Psychiatry 1993;150:112.
52. Tejera C, Mayerhoff D, Safferman A, Ramos-Lorenzi J. Fluoxetine for obsessional symptoms in schizophrenia. Am J Psychiatry 1994;151:149-50.
53. Poyurovsky M, Isakov V, Hromnikov S, Modai I, Rauchberger B, Schneidman M, et coll. Fluvoxamine treatment of obsessive-compulsive symptoms in schizophrenic patients: an add-on open study. Int Clin Psychopharmacol 1999;14:95-100.
54. Reznik L, Sirota P. An open study of fluvoxamine augmentation of neuroleptics in schizophrenia with obsessive and compulsive symptoms. Clin Neuropharmacol 2000;23:157-60.
55. Reznik I, Sirota P. Obsessive and compulsive symptoms in schizophrenia: a randomized controlled trial with fluvoxamine and neuroleptics. J Clin Psychopharmacol 2000;20:410-6.
56. Goff DC, Midha KK, Brotman AW, Waites M, Baldessarini RY. Elevation of plasma concentrations of haloperidol after addition of fluoxetine. Am J Psychiatry 1991;148:790-2.
57. Dequardo JR, Roberts M. Elevated clozapine levels after fluvoxamine initiation. Am J Psychiatry 1996;153:840-1.
58. Centorrino F, Baldesarrini RJ, Frankenburg FR, Kando J, Volpicelli SA, Flood JG. Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors. Am J Psychiatry 1996;153:820-2.
59. Rector NA, Beck AT. Cognitive therapy for schizophrenia: from conceptualization to intervention. Can J Psychiatry 2002;47:39-48.